Cargando…

Secondary leukemia

Detalles Bibliográficos
Autor principal:	Hasle, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	EHA23 Educational Updates in Hematology Book
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925570/ http://dx.doi.org/10.1097/HS9.0000000000000104

Ejemplares similares

Biology of secondary leukemia
por: Brunner, Andrew M., et al.
Publicado: (2018)

Prognostic factors and treatment of secondary leukemia
por: Voso, Maria Teresa, et al.
Publicado: (2018)

Epidemiology and impact of preceding or underlying disease in secondary acute myeloid leukemia
por: Granfeldt Østgård, Lene Sofie, et al.
Publicado: (2018)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Chronic lymphocytic leukemia
por: Rossi, Davide
Publicado: (2018)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Advances in acute lymphoblastic leukemia genomics
por: Harrison, Christine J., et al.
Publicado: (2018)

Epigenetic treatment and beyond in acute myeloid leukemia
por: Wei, Andrew
Publicado: (2018)

Single cell genomics in chronic myeloid leukemia
por: Mead, Adam J.
Publicado: (2018)

Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018)

New concepts in acute lymphoblastic leukemia frontline trials
por: Oskarsson, Trausti, et al.
Publicado: (2018)

Immune targeting of chronic myeloid leukemia to improve treatment outcome
por: Burchert, Andreas
Publicado: (2018)

Mechanisms underlying transcription factor deregulation in acute lymphoblastic leukemia
por: Cools, Jan
Publicado: (2018)

Towards control of chronic lymphocytic leukemia using chemotherapy-free combinations
por: Hallek, Michael
Publicado: (2018)

Lymphoma immunotherapy
por: Zinzani, Pier Luigi
Publicado: (2018)

Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas
por: Borchmann, Peter
Publicado: (2018)

The spleen: Neglected but essential
por: Buffet, Pierre
Publicado: (2018)

Facing the challenge: Novel treatment options for patients with myelodysplastic syndromes
por: Kubasch, Anne Sophie, et al.
Publicado: (2018)

Molecular genetics in clinical decision making for patients with myelodysplastic syndromes or related disorders
por: Cazzola, Mario
Publicado: (2018)

Iron & disease
por: Camaschella, Clara
Publicado: (2018)

Methods to detect minimal residual disease
por: Haferlach, Torsten
Publicado: (2018)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

Cancer associated thrombosis: Which lessons for the hematologist?
por: Noble, Simon
Publicado: (2018)

Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
por: Versluis, Jurjen, et al.
Publicado: (2018)

The spleen in immune thrombocytopenia
por: Geyer, Julia T., et al.
Publicado: (2018)

Optimization of the first line treatment in classical Hodgkin's lymphoma
por: Brice, Pauline
Publicado: (2018)

Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018)

From antibiotics to ibrutinib: An array of treatment modalities
por: Thieblemont, Catherine
Publicado: (2018)

Multiple myeloma
por: Delforge, Michel
Publicado: (2018)

Marginal zone lymphoma: Diagnostic challenges among different entities
por: Bongiovanni, Lucia, et al.
Publicado: (2018)

Stem cell transplantation
por: Höglund, Martin
Publicado: (2018)

Stem cell transplantation: preventing relapse of transplant
por: Craddock, Charles
Publicado: (2018)

Switching genes on and off during Erythropoiesis
por: Higgs, Douglas R., et al.
Publicado: (2018)

Pathogenesis of cancer-associated thrombosis
por: Mackman, Nigel
Publicado: (2018)

Treatment-free remission: A new goal for all chronic phase (CP)-CML patients
por: Rea, Delphine
Publicado: (2018)

What's ahead in the treatment of hemophilia
por: Rodeghiero, Francesco
Publicado: (2018)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

The microenvironment in myelodysplastic syndromes: From concept to therapeutic target
por: Raaijmakers, Marc H.G.P.
Publicado: (2018)

New therapeutic approaches for hemoglobinopathies: Pharmacologic agents impacting pathophysiology
por: Abboud, Miguel R.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c3mapietooki2js5hkr2h473ia